Imperial Innovations Group Share News (IVO)
IVO Share
IVO Share
IVO Share
IVO Share
IVO
IVO Share
IVO Broker
IVO Directors
IVO Financial
IVO
IVO Short
IVO
Martin Gilbert, Chairman of FTSE 250 transport firm FirstGroup, has ignored broker recommendations to purchase 50,000 shares on the same day the company unveiled its plans to move its UK bus shake-up into the fast lane. Gilbert bought the shares on Wednesday at 217.50p each for a total of £108,750
Read moreImperial Innovations, which invests in the commercialisation of technology, kept piling cash into new ventures despite profits falling in the first half. The firm said profits during the six months to the end of January were £0.9m, down from £1.3m the year before. During this time it invested £10.
Read moreFFastFill, a 'Software-as-a-Service' provider, announced that INTL FCStone (formerly Ambrian Commodities), the metals futures trading arm of Ambrian Capital, has signed for both its Trading Pro, SEALS and Eclipse applications for execution, matching and settlement. The contract win takes the number
Read moreTechnology investment group, Imperial Innovations, said it was pumping £1.3m into new Cambridge drug development firm Mission Therapeutics. The investment is part of a £6m funding round at Mission, which will focus on oncology. The deal will leave Imperial with 15.7% equity in the firm. In Decembe
Read moreShares in IPSO Ventures tumbled to a new low after the technology commercialisation group posted a pre-tax loss in the year to 30 April amid "challenging" trading. IPSO exploits innovations developed by researchers in universities and other institutions. Pre-tax profits losses narrowed to £424,000
Read moreImperial Innovations Group, the technology commercialisation and investment group, saw pre-tax profit jump to £1.3m, from £0.1m, in the half year ended 31 January 2011. The firm raised £140m in new equity during the period to increase investment in selected companies established in conjunction with
Read moreJohn Manser, who has been a non-executive director of SABMiller for a decade has bought 5,000 shares in the brewer. Manser paid 2083.82p a share for the 5,000 shares, which cost a total of £104,000. He has taken advantage of the weakness in the share price since the beginning of 2011. Organic vo
Read moreNiche engineer Renishaw's halfway statement to January 26 yesterday was full of superlatives. First-half revenues were 26% higher than their previous high point and pre-tax profits were 132% higher. Numis Securities calculates £72.2m in profits this year against less than £30m last time, which puts
Read moreDrax non-executive director Tony Thorne has bought £28,000 worth of shares in the power generator. He has paid 378.69p a share for 7,500 shares. Thorne was appointed to the board in June and these are the first shares he has bought. Thorne is a former chief executive of paper company DS Smith.
Read moreTechnology commercialisation outfit Imperial Innovations is raising £140m to invest in companies founded in Imperial College and other top British universities. It is raising the money by issuing two new shares for every three existing shares at 350p a share. The money will be used to accelerate
Read moreOrosur Mining had a "good" first quarter as an increase in production to the upper end of expectations aided a swing to profit for the three months ended August 31. The company reported net income of $3.5m compared with a loss of $2.2m a year ago as output hit 12,937 ounces of gold and the average
Read moreImperial Innovations is starting to make strong gains on exits from its portfolio, selling Thiakis, the developer of an anti-obesity drug, to America's Wyeth and, last week, disposing of Respivert, the maker of a respiratory treatment, to an offshoot of Johnson & Johnson. At 474½p, tuck away. The I
Read moreTelecommunications software group Globo's shares surged after it said it would be providing its CitronGo! platform that allows users of devices to access their e-mail and other services to a Southeast Asian mobile operator with more than 85m subscribers. Imperial Innovations, which commercialises t
Read moreProfessor Barry Furr, a non-executive director at the animal breeding technology group Genus, has spent £30,000 more than doubling his stake in the animal breeding company, the firm confirmed today. He bought 5,000 shares at 600p a time and now has 8,000. Furr, a former chief scientist for the dru
Read more